Correlation Between Reckitt Benckiser and Kobayashi Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Reckitt Benckiser and Kobayashi Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reckitt Benckiser and Kobayashi Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reckitt Benckiser Group and Kobayashi Pharmaceutical Co, you can compare the effects of market volatilities on Reckitt Benckiser and Kobayashi Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reckitt Benckiser with a short position of Kobayashi Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reckitt Benckiser and Kobayashi Pharmaceutical.
Diversification Opportunities for Reckitt Benckiser and Kobayashi Pharmaceutical
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reckitt and Kobayashi is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Reckitt Benckiser Group and Kobayashi Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kobayashi Pharmaceutical and Reckitt Benckiser is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reckitt Benckiser Group are associated (or correlated) with Kobayashi Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kobayashi Pharmaceutical has no effect on the direction of Reckitt Benckiser i.e., Reckitt Benckiser and Kobayashi Pharmaceutical go up and down completely randomly.
Pair Corralation between Reckitt Benckiser and Kobayashi Pharmaceutical
Assuming the 90 days horizon Reckitt Benckiser Group is expected to generate 0.02 times more return on investment than Kobayashi Pharmaceutical. However, Reckitt Benckiser Group is 54.78 times less risky than Kobayashi Pharmaceutical. It trades about 0.0 of its potential returns per unit of risk. Kobayashi Pharmaceutical Co is currently generating about -0.06 per unit of risk. If you would invest 1,315 in Reckitt Benckiser Group on September 1, 2024 and sell it today you would lose (71.00) from holding Reckitt Benckiser Group or give up 5.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 66.67% |
| Values | Daily Returns |
Reckitt Benckiser Group vs. Kobayashi Pharmaceutical Co
Performance |
| Timeline |
| Reckitt Benckiser |
| Kobayashi Pharmaceutical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Reckitt Benckiser and Kobayashi Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reckitt Benckiser and Kobayashi Pharmaceutical
The main advantage of trading using opposite Reckitt Benckiser and Kobayashi Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reckitt Benckiser position performs unexpectedly, Kobayashi Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kobayashi Pharmaceutical will offset losses from the drop in Kobayashi Pharmaceutical's long position.| Reckitt Benckiser vs. LOral SA | Reckitt Benckiser vs. LOreal Co ADR | Reckitt Benckiser vs. Unilever PLC ADR | Reckitt Benckiser vs. Kimberly Clark |
| Kobayashi Pharmaceutical vs. Sun Country Airlines | Kobayashi Pharmaceutical vs. Stepstone Group | Kobayashi Pharmaceutical vs. Old Dominion Freight | Kobayashi Pharmaceutical vs. Procter Gamble |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |